Biometrics

1954, 8: 101–129.CrossRef 22. Hareyama M, Sakata K, Oouchi A, Nagakura H, Shido M, Someya M, Koito K: High-dose-rate versus low-dose-rate intracavitarytherapy for carcinoma of the uterine cervix: a randomized trial. Cancer 2002, 1; 94 (1) : 117–24.CrossRef 23. Patel FD, Sharma SC, Negi PS, Ghoshal S, Gupta BD: Lowdose rate vs. high dose rate brachytherapy in the treatment ofcarcinoma of the uterine cervix: a clinical trial. Int J Radiat Oncol Biol Phys 1994, 15; 28 (2) : 335–41. 24. Teshima T, Inoue T, Ikeda H, Miyata Y, Nishiyama K, Inoue T, Murayama S, Yamasaki H, Kozuka T: High-dose rate and low-doserate intracavitary therapy for carcinoma of the uterine cervix. Final results of Osaka PCI-32765 datasheet University Hospital. Cancer 1993, 15; 72 (8) : 2409–14.CrossRef 25. Lertsanguansinchai P, Lertbutsayanukul C, Shotelersuk Elacridar cost K, Khorprasert C, Rojpornpradit P, Chottetanaprasith T, Srisuthep A, Suriyapee S, Jumpangern C, Tresukosol D, Charoonsantikul C: Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma. Int J Radiat Oncol Biol Phys 2004, 59 (5) : 1424–1431.CrossRefPubMed 26. Shrivastava S, Dinshaw K, Mahantshetty U, Engineer R, Patil N, Deshpande D, Tongaonkar H: Comparing Low-Dose-Rate andHigh-Dose-Rate Intracavitary Brachytherapy in Carcinoma Cervix: Results From a Randomized Controlled Study. Int J Radiat Oncol Biol 3-deazaneplanocin A Phys 2006, 1; 66 (3) : S42. 27. Jemal A, Siegel R, Ward

E, et al.: Cancer statistics, 2008. CA Cancer J Clin 2008, 58: 71.CrossRefPubMed 28. Lowndes CM, Gill ON: Cervical cancer, human papillomavirus, and vaccination. BMJ 2005, 331: 915–916.CrossRefPubMed 29. Parkin DM, Bray F, Ferlay J, Pisani P: Global Cancer Statistics, 2002. CA Cancer J Clin 2005, 55: 74–108.CrossRefPubMed 30. Nag S, Erickson B, Thomadsen B: The American Brachytherapy Society recommendations for high-dose-rate Cobimetinib nmr brachytherapy for carcinoma of the

cervix. Int J Rad Oncol Biol Phys 2000, 48: 201–221.CrossRef 31. Fyles AW, Pintilie M, Kirkbridge P: Prognostic factors in patients with cervix cancer treated by radiation therapy: Results of a multiple regression analysis. Radiother Oncol 1995, 35: 107–117.CrossRefPubMed 32. Barillot I, Horiot JC, Pigneaux J: Carcinoma of the intact uterine cervix treated with radiotherapy alone: A French Cooperative Study: Update and multivariate analysis of prognostic factors. Int J Radiat Oncol Biol Phys 1997, 38: 969–978.CrossRefPubMed 33. Kim RY, Trotti A, Wu CJ: Radiation alone in the treatment of cancer of the uterine cervix: Analysis of pelvic failure and dose response relationship. Int J Radiat Oncol Biol Phys 1989, 17: 973–991.CrossRefPubMed 34. Lanciano RM, Martz KL, Coia LR: Tumor and treatment factors improving outcome in staging IIIB cervix cancer. Int J Radiat Oncol Biol Phys 1991, 20: 95–108.CrossRefPubMed 35. Montana GS, Fowler WC, Varia MA: Carcinoma of the cervix, stage III: Results of radiation therapy. Cancer 1986, 57: 148–154.CrossRefPubMed 36.